Bone marrow-derived mesenchymal stem cells attenuate amyloid β-induced memory impairment and apoptosis by inhibiting neuronal cell death

Current Alzheimer Research

Volumn 7, Issue 6, 2010, Pages 540-548

  Lee, J K ^a,b   Jin, H K ^a   Bae, J S ^a,b  

^a Kyungpook National University   (South Korea)

^b Kyungpook National University School of Medicine   (South Korea)

Author keywords

Acutely induced Alzheimer's disease mouse model; Apoptosis; Bone marrow derived mesenchymal stem cell; Spatial learning and memory; Transplantation

Indexed keywords

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CELL SURVIVAL; CONTROLLED STUDY; HIPPOCAMPUS; IN VITRO STUDY; IN VIVO STUDY; MEMORY DISORDER; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NERVE CELL; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL;

AMYLOID BETA-PEPTIDES; ANIMALS; APOPTOSIS; BONE MARROW TRANSPLANTATION; BUTADIENES; CELLS, CULTURED; CREB-BINDING PROTEIN; DISEASE MODELS, ANIMAL; EMBRYO, MAMMALIAN; ENZYME INHIBITORS; ETHIDIUM; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HIPPOCAMPUS; IN SITU NICK-END LABELING; MAZE LEARNING; MEMORY DISORDERS; MESENCHYMAL STEM CELL TRANSPLANTATION; MICE; MICE, INBRED C57BL; NEURONS; NITRILES; OXIDATIVE STRESS; PHOSPHORYLATION; REACTION TIME; STATISTICS, NONPARAMETRIC; SUPEROXIDES;

EID: 78549293251     PISSN: 15672050     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720510792231739     Document Type: Article

References (44)

1. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297: 353-356 (2002).
2. Engler H, Forsberg A, Almkvist O, Blomquist G, Larsson E, Savitcheva I, et al. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease. Brain 129: 2856-2866 (2006).
3. Holmes C, Boche D, Wilkinson D, Yadegarfar G, Hopkins V, Bayer A, et al. Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial. Lancet 372: 216-23 (2008).
4. Eckert A, Keil U, Marques CA, Bonert A, Frey C, Schüssel K, et al. Mitochondrial dysfunction, apoptotic cell death, and Alzheimer's disease. Biochem Pharmacol 66: 1627-1634 (2003).
5. Vellas B, Black R, Thal LJ, Fox NC, Daniels M, McLennan G, et al. Long-term follow-up of patients immunized with AN1792: reduced functional decline in antibody responders. Curr Alzheimer Res. 6: 144-151 (2009).
6. Yang TT, Hsu CT, Kuo YM. Cell-derived soluble oligomers of human amyloid-beta peptides disturb cellular homeostasis and induce apoptosis in primary hippocampal neurons. J Neural Transm. 116: 1561-1569 (2009).
7. Vila M, Przedborski S. Targeting programmed cell death in neurodegenerative disease. Nat Rev Neurosci 4: 365-375 (2003).
8. Billings LM, Oddo S, Green KN, McGaugh JL, LaFerla FM. Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron 45: 675-688 (2005).
9. Zhang J, Li Y, Chen J, Cui Y, Lu M, Elias SB, et al. Human bone marrow stromal cell treatment improves neurological functional recovery in EAE mice. Exp Neurol 195: 16-26 (2005).
10. Zhang J, Li Y, Chen J, Yang M, Katakowski M, Lu M, et al. Expression of insulin-like growth factor 1 and receptor in ischemic rats treated with human marrow stromal cells. Brain Res 1030: 19-27 (2004).
11. Ren G, Li T, Lan JQ, Wilz A, Simon RP, Boison D. Lentiviral RNAi-induced downregulation of adenosine kinase in human mesenchymal stem cell grafts: a novel perspective for seizure control. Exp Neurol 208: 26-37 (2007).
12. Le Blanc K. Mesenchymal stromal cells: Tissue repair and immune modulation. Cytotherapy 8: 559-561 (2006).
13. Gupta N, Su X, Popov B, Lee JW, Serikov V, Matthay MA. Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J Immunol 179: 1855-1863 (2007).
14. Xu G, Zhang L, Ren G, Yuan Z, Zhang Y, Zhao RC, et al. Immunosuppressive properties of cloned bone marrow mesenchymal stem cells. Cell Res 17: 240-248 (2007).
15. Block GJ, Ohkouchi S, Fung F, Frenkel J, Gregory C, Pochampally R, et al. Multipotent Stromal Cells (MSCs) are Activated to Reduce Apoptosis in Part by Upregulation and Secretion of Stanniocalcin-1 (STC-1). Stem Cells 27: 670-681 (2009).
16. Brewer GJ, Torricelli JR, Evege EK, Price PJ. Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serum-free medium combination. J Neurosci Res 35: 567-576 (1993).
17. Lee JK, Jin HK, Bae JS. Bone marrow-derived mesenchymal stem cells reduce brain amyloid-beta deposition and accelerate the activation of microglia in an acutely induced Alzheimer's disease mouse model. Neurosci Lett 450: 136-141 (2009).
18. Troy CM, Rabacchi SA, Freidman WJ, Frappier TF, Brown K, Shelanski ML. Caspase-2 mediates neuronal cell death induced by β-amyloid. J Neurosci 20: 1386-1392 (2000).
19. Tsai KJ, Tsai YC, Shen CK. G-CSF rescues the memory impairment of animal models of Alzheimer's disease. J Exp Med 204: 1273-1280 (2007).
20. Morris RG, Garrud P, Rawlins JN, O'Keefe J. Place navigation impaired in rats with hippocampal lesion. Nature 297: 681-683 (1982).
21. Sweatt JD. The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory. J Neurochem 76: 1-10 (2001).
22. Silva AJ, Kogan JH, Frankland PW, Kida S. CREB and memory. Annu Rev Neurosci 21: 127-148 (1998).
23. Wilson BE, Mochon E, Boxer LM. Induction of bcl-2 expression by phosphorylated CREB proteins during B-cell activation and rescue from apoptosis. Mol Cell Biol 16: 5546-5556 (1996).
24. Cancino GI, Toledo EM, Leal NR, Hernandez DE, Yévenes LF, Inestrosa NC, et al. STI571 prevents apoptosis, tau phosphorylation and behavioural impairments induced by Alzheimer's beta-amyloid deposits. Brain 131: 2425-2442 (2008).
25. Frautschy SA, Hu W, Kim P, Miller SA, Chu T, Harris-White ME, et al. Phenolic anti-inflammatory antioxidant reversal of Aβ-induced cognitive deficits and neuropathology. Neurobiol Aging 22: 993-1005 (2001).
26. Lim GP, Chu T, Yang F, Beech W, Frautschy SA and Cole GM. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci 21: 8370-8377 (2001).
27. Hardy J. A hundred years of Alzheimer's disease research. Neuron 52: 3-13 (2006).
28. Walsh DM, Selkoe DJ. Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron 44: 181-193 (2004).
29. Chen X, Li Y, Wang L, Katakowski M, Zhang L, Chen J, et al. Ischemic rat brain extracts induce human marrow stromal cell growth factor production. Neuropathology 22: 275-279 (2002).
30. Chen X, Katakowski M, Li Y, Lu D, Wang L, Zhang L, et al. Human bone marrow stromal cell cultures conditioned by traumatic brain tissue extracts: growth factor production. J Neurosci Res 69: 687-691 (2002).
31. Mahmood A, Lu D, Chopp M. Intravenous administration of marrow stromal cells (MSCs) increases the expression of growth factors in rat brain after traumatic brain injury. J Neurotrauma 21: 33-39 (2004).
32. Crowder RJ and Freeman RS. Phosphatidylinositol 3-kinase and Akt protein kinase are necessary and sufficient for the survival of nerve growth factor-dependent sympathetic neurons. J Neurosci 18: 2933-2943 (1998).
33. Philpott KL, McCarthy MJ, Klippel A, Rubin LL. Activated phosphatidylinositol 3-kinase and Akt kinase promote survival of superior cervical neurons. J Cell Biol 139: 809-815 (1997).
34. Jiang Z, Zhang Y, Chen X, Lam PY, Yang H, Xu Q, et al. Apoptosis and activation of Erkl/2 and Akt in astrocytes postischemia. Neurochem Res 28: 831-837 (2003).
35. Anderson CN, Tolkovsky AM. A role for MAPK/ERK in sympathetic neuron survival: protection against a p53-dependent, JNKindependent induction of apoptosis by cytosine arabinoside. J Neurosci 19: 664-673 (1999).
36. Chang L, Karin M. Mammalian MAP kinase signalling cascades. Nature 410: 37-40 (2001).
37. Zhu Y, Yang GY, Ahlemeyer B, Pang L, Che XM, et al. Transforming growth factor-beta 1 increases bad phosphorylation and protects neurons against damage. J Neurosci 22: 3898-3909 (2002).
38. Gao Q, Li Y, Chopp M. Bone marrow stromal cells increase astrocyte survival via upregulation of phosphoinositide 3-kinase/threonine protein kinase and mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathways and stimulate astrocyte trophic factor gene expression after anaerobic insult. Neuroscience 136: 123-134 (2005).
39. Chen J, Zhang ZG, Li Y, Wang L, Xu YX, Gautam SC, et al. Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats. Circ Res 92: 692-699 (2003).
40. Kim DH, Kim S, Jeon SJ, Son KH, Lee S, Yoon BH, et al. The effects of acute and repeated oroxylin A treatments on Abeta (25-35)-induced memory impairment in mice. Neuropharmacology 55: 639-647 (2008).
41. Chang RC, Suen KC, Ma CH, Elyaman W, Ng HK, Hugon J. Involvement of double-stranded RNA-dependent protein kinase and phosphorylation of eukaryotic initiation factor-2alpha in neuronal degeneration. J Neurochem 83: 1215-1225 (2002).
42. Butterfield DA, Boyd-Kimball D. Amyloid beta-peptide(1-42) contributes to the oxidative stress and neurodegeneration found in Alzheimer disease brain. Brain Pathol 14: 426-432 (2004).
43. Behl C, Davis JB, Lesley R, Schubert D. Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 77: 817-827 (1994).
44. Ratan RR, Baraban JM. Apoptotic death in an in vitro model of neuronal oxidative stress. Clin Exp Pharmacol Physiol 22: 309-310 (1995).